Midgard Science

Canthera Discovery

Melbourne, Australia cantheradiscovery.com

From their website, Nov 2026

Work here? Claim this listing

About

Canthera Discovery is an oncology-focused small molecule drug discovery and development organisation in Melbourne, Australia. It works with research institutes, universities, biotechnology companies, and industry partners to move cancer research into preclinical and clinical development.

Services

  • Collaborative partnerships

    Builds project teams with multiple institutes and disciplines to support drug discovery collaborations and data-driven decision-making.

  • e-Research Technologies

    Provides data management, analysis, visualization tools, and an electronic laboratory notebook for standardized research data capture and sharing.

  • Translational cancer biology

    Develops and validates target-specific functional bioassays, biomarker assays, in vivo models, and imaging strategies for evaluating novel compounds.

  • Drug metabolism and pharmacokinetics

    Provides physicochemical profiling, permeability, metabolism, metabolite profiling, drug-drug interaction analysis, in vivo pharmacokinetics, stability testing, impurity profiling, preclinical formulation development, solid-state characterization, and salt sel

    ADME, DMPK & toxicology

  • Structural biology

    Determines protein structures and protein/inhibitor complexes using crystallography, in-house crystallization labs, the Australian Synchrotron, and X-ray facilities.

  • Recombinant protein production

    Produces, purifies, and characterizes recombinant proteins from bacterial, insect, and mammalian cell lines for high-throughput screening and structural studies.

    Protein production

  • Medicinal chemistry

    Supports HTS triage, lead generation, and lead optimization to identify and optimize lead series toward clinical candidates.

  • High throughput screening

    Develops and miniaturises molecular, cell-based, and high-content assays, runs HTS campaigns, and uses compound management and fragment screening capabilities.

Capabilities

Processes
Small molecule · Recombinant protein · Small molecules · HTS · PK/PD
Capacity
Two established HTS facilities in Australia · More than 100 HTS campaigns · More than 100 proteins produced successfully · More than 50 collaborative drug discovery programs · More than 15 novel candidates moved into clinical development

Equipment

  • Australian Synchrotron
  • Rigaku MicroMax 007HF
  • RAXIS4++ area detector
  • Electronic laboratory notebook (ELN)

Materials

  • Insect cells

Industries served

  • Biotechnology
  • Pharmaceutical

Company

Type
CRDMO
Founded
2007

Locations

Address
305 Grattan Street Melbourne Victoria 3000
Sites
Melbourne, Australia
Serves
Australia

Contacts

Similar labs

Work here? Claim this listing